Equity Overview
Price & Market Data
Price: $1.86
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $93,262,448
Volume: 0
Performance Metrics
1 Week: 12.73%
1 Month: 10.71%
3 Months: -2.11%
6 Months: -1.06%
1 Year: -84.88%
YTD: -10.14%
Company Details
Employees: 14
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda for the commercialization of any pharmaceutical products with HIL-214 compounds. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.